NCT00161902

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Hemostasis in Subjects Undergoing Total Hip Replacement

A Randomized, Controlled, Multicenter Study to Evaluate Efficacy and Safety of Fibrin Sealant VH S/D for Hemostasis in Subjects Undergoing Total Hip Replacement

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: —
• Sponsor: Baxter Healthcare Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: —

Summary

The purpose of the study is to monitor the safety of FS VH S/D and evaluate whether FS VH S/D is superior to standard treatment in reducing blood loss in subjects undergoing total hip replacement with cement-free hip prostheses.

Conditions

• Hip Replacement Surgery

Interventions

Type	Name	Description
DRUG	Fibrin Sealant Vapor-Heated Solvent/Detergent-treated

Timeline

• Start date: 2001-08-01
• Completion: 2003-03-01
• First posted: 2005-09-13
• Last updated: 2006-10-23

Locations

7 sites across 3 countries: Austria, Germany, Netherlands